Abstract
A virtual screening protocol with combination of similarity search and pharmacophore-modelling was applied to virtually screen a large compound library to gain new scaffolds regarding ABCC1 inhibition. Biological investigation of promising candidates revealed nine compounds as ABCC1 inhibitors, five of them with scaffolds not associated with ABCC1 inhibition until now. The best hit molecule – a thienopyrimidine – was a moderately potent, competitive inhibitor of the ABCC1-mediated transport of calcein AM which also sensitized ABCC1-overexpressing cells toward daunorubicin. Further evaluation showed that it was a moderately potent, competitive inhibitor of the ABCB1-mediated transport of calcein AM, and noncompetitive inhibitor of the pheophorbide A transport by ABCG2. In addition, the thienopyrimidine could also sensitize ABCB1- as well as ABCG2-overexpressing cells toward daunorubicin and SN-38, respectively, in concentration ranges that qualified it as one of the ten best triple ABCC1/ABCB1/ABCG2 inhibitors in literature. Besides, seven more new multi-target inhibitors were identified by this virtual screening approach.

This publication has 90 references indexed in Scilit: